Genmab A (GMAB) Profit After Tax (2018 - 2026)

Genmab A has reported Profit After Tax for 6 years, with the latest figure at $53.0 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 72.82% year-over-year to $53.0 million; the trailing twelve-month figure through Mar 2026 stood at $985.0 million (up 26.93% YoY), and the FY2025 full-year result was $963.0 million, down 15.0% from the prior year.
• Profit After Tax for Q1 2026 stood at $53.0 million, down from $401.0 million in the prior quarter.
• The five-year high for Profit After Tax was $401.0 million in Q3 2025, with the low at $53.0 million in Q1 2026.
• Historically, Profit After Tax has averaged $223.7 million across 3 years, with a median of $195.0 million in 2025.
• Annual changes were most pronounced in 2025 — Profit After Tax jumped 115.59% — and 2026, when it tumbled 72.82%.
• Genmab A's Profit After Tax stood at $186.0 million in 2024, then soared by 115.59% to $401.0 million in 2025, then tumbled by 86.78% to $53.0 million in 2026.
• The last three Profit After Tax figures came in at $53.0 million (Q1 2026), $401.0 million (Q3 2025), and $336.0 million (Q2 2025), per Business Quant data.